Global Health Headlines: Polio in Gaza, Maternal Health Investments, Mpox Outbreaks, and More

Health news highlights include the reemergence of polio in Gaza, increased investment in maternal health by venture capital firms, and the Democratic Republic of the Congo's anticipated mpox vaccine. Additional reports cover cases of mpox in Pakistan and the Philippines, regulatory issues for Liquidia, and a challenge to Canada's assisted death framework.

Health news highlights from around the globe cover the pressing issues in various regions. Notably, Gaza is facing a polio resurgence, alarming for parents like Ghada al-Ghandour. Venture capital is increasingly targeting maternal health, with companies like Mae innovating solutions.

In the Democratic Republic of the Congo, the health ministry hopes to receive its first mpox vaccines soon. Meanwhile, Pakistan has detected a clade 2 mpox case, and the Philippines has reported its first case of the year. Liquidia Corp's lung disorder drug approval has been delayed by the FDA, impacting its stock significantly.

Canada's legal challenge over mental illness exclusion from assisted death policies is underway. Additionally, Emergent BioSolutions is addressing the mpox outbreak in Africa through significant vaccine donations, and BioNTech has resumed a cancer drug trial after meeting FDA requirements. Lastly, safety concerns over India's spice quality persist.

(With inputs from agencies.)